Molecular Diagnosis and Prognosis of Ductal Carcinoma In Situ (DCIS)
A novel molecular marker that provides a reliable prognostic indicator for DCIS breast cancer patients
Published: 28th July 2022

IP Status
- Patented
Seeking
- Licensing
A novel molecular marker that provides a reliable prognostic indicator for DCIS breast cancer patients